2012-09-18 08:06:28 - New Pharmaceuticals market report from Global Markets Direct: "Acute Pain - Pipeline Review, H2 2012"

Global Markets Direct's, 'Acute Pain - Pipeline Review, H2 2012', provides an overview of the Acute Pain therapeutic pipeline. This report provides information on the therapeutic development for Acute Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute Pain. 'Acute Pain - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the

indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Acute Pain.
* A review of the Acute Pain products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Acute Pain pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/463860_acute_pain_pipeline_review_h2_2012.as ..


Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Acute Pain.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Acute Pain pipeline depth and focus of Acute Pain therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Keywords

Acute Pain Therapeutic Products under Development, Key Players in Acute Pain Therapeutics, Acute Pain Pipeline Overview, Acute Pain Pipeline, Acute Pain Pipeline Assessment

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Acute Pain Overview
Therapeutics Development
An Overview of Pipeline Products for Acute Pain
Acute Pain Therapeutics under Development by Companies
Acute Pain Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Acute Pain Therapeutics - Products under Development by Companies
Acute Pain Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Acute Pain Therapeutics Development
Abbott Laboratories
Nektar Therapeutics
Acusphere, Inc.
A.P. Pharma, Inc.
Pacira Pharmaceuticals, Inc.
AcelRx Pharmaceuticals, Inc.
Cubist Pharmaceuticals, Inc.
Sun Pharmaceutical Industries Limited
Anavex Life Sciences Corp.
NeurogesX, Inc.
Nuvo Research Inc.
CombinatoRx, Incorporated
Array BioPharma Inc.
Orexo AB
Intas Pharmaceuticals Ltd.
Advinus Therapeutics Pvt. Ltd.
Transdel Pharmaceuticals, Inc.
BIOALVO S.A.
AngioChem Inc.
Trevena, Inc.
QRxPharma Limited
Cara Therapeutics, Inc.
Xenome Ltd.
Iroko Pharmaceuticals, LLC
Xanodyne Pharmaceuticals, Inc.
Antibe Therapeutics, Inc.
Pierre Fabre Medicament
Troikaa Pharmaceuticals Ltd.
Nautilus Neurosciences, Inc.
RaQualia Pharma Inc.
Cytogel Pharma, LLC
Madeira Therapeutics
Acute Pain - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Ketotransdel - Drug Profile
CR 4056 - Drug Profile
BLV0704 - Drug Profile
Vicodin CR - Drug Profile
Nucynta - Drug Profile
ARRY-797 - Drug Profile
NGX-1576 - Drug Profile
NGX-9674 - Drug Profile
NGX-5752 - Drug Profile
NGX-6052 - Drug Profile
buprenorphine hydrochloride - Drug Profile
AI-525 - Drug Profile
PRO-571 - Drug Profile
ANAVEX-1007 - Drug Profile
IV CR845 - Drug Profile
XP21B - Drug Profile
MoxDuo IR - Drug Profile
Eptifibatide - Drug Profile
Xen2174 - Drug Profile
ANAVEX-1519 - Drug Profile
Ketamine - Drug Profile
ANG2002 - Drug Profile
K-Opioid Receptor Biased Ligand Program - Drug Profile
Sufentanil - Drug Profile
RQ-00000008 - Drug Profile
Topical Diclofenac Solution - Drug Profile
IN-PHARM-002 - Drug Profile
D-9998 - Drug Profile
NCE 1 - Drug Profile
NCE 2 - Drug Profile
IP 940 - Drug Profile
IP 880 - Drug Profile
Z-212 - Drug Profile
OX51 - Drug Profile
DepoNSAID - Drug Profile
Mu-Opiod Receptor Biased Ligand Program - Drug Profile
ARX-04 - Drug Profile
ANAVEX-1066 - Drug Profile
NRI-ANA - Drug Profile
MRX-7EAT - Drug Profile
THA903 - Drug Profile
Cyt-1010 - Drug Profile
NKTR-192 - Drug Profile
T109 - Drug Profile
ABT-594 - Drug Profile
RQ-00317076 - Drug Profile
ATB-346 - Drug Profile
Target 1 For Pain - Drug Profile
V0498TA01A - Drug Profile
CB-625 - Drug Profile

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=463860&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.